AR

Anubhav Rai

Active Director Director DIN 09709035
DIN 09709035 First appointment Aug 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value •••• Premium profile

About Anubhav Rai

Data last updated:

Anubhav Rai is a Director at Oshawa Pharma Private Limited (since 2022). The company operates in Chemicals. Oshawa Pharma Private Limited reported revenue of ₹21.6 Lakh (FY 2025).

DIN 09709035
Primary Designation Director
Industry Chemicals
First Appointment 20 Aug 2022
Oldest Company Age 4 yrs
Largest company Oshawa Pharma Private Limited · ₹21.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Oshawa Pharma Private Limited U24290UP2022PTC169217
Director20 Aug 20222022₹21.6 Lakh (FY 2025)Active

Board colleagues of Anubhav Rai

NameDINCompanyDesignation
Krishna Kumar Rai09709034Oshawa Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Oshawa Pharma Private Limited
Premium access

Shareholding and investment profile for Anubhav Rai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anubhav Rai

Anubhav Rai currently holds 1 directorship: Oshawa Pharma Private Limited (Director, since 20 Aug 2022, revenue ₹21.6 Lakh (FY 2025)).

Anubhav Rai was first appointed on 20 Aug 2022 as Director at Oshawa Pharma Private Limited.

The current boards of Anubhav Rai's companies include Krishna Kumar Rai (Oshawa Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available